Table 1.

Characteristics of Patients Colonized with Methicillin-Resistant Staphylococcus aureus (MRSA) Who Were Eligible for Intranasal Mupirocin Therapy

Variable	Patients Treated with Mupirocin (n=16)	Patients Not Treated with Mupirocin (n=8)	P
Demographic
Gender (female)	7 (44)	5 (63)	0.67
Birth Weight, grams (median, IQR)	875 (700-2555)	1180 (770-2170)	0.84
Gestational Age, weeks (median, IQR)	30 (25–36)	28 (26–34)	0.85
Race			0.42
African American	10 (63)	4 (50)
Caucasian	4 (25)	4 (50)
Hispanic	2 (13)	0
Clinical
Age at first MRSA culture, days (median, IQR)	46 (23–69)	49 (33–86)	0.62
Days in unit before first MRSA culture (median, IQR)	23 (13–53)	11 (0–51)	0.26
Indwelling central venous catheter at time of first MRSA culture	12 (75)	3 (38)	0.10
Mechanical ventilation at time of first MRSA culture	4 (25)	4 (50)	0.33
Follow-up time after colonization, days (medians, IQR)	25 (20–38)	13.5 (3–26)	0.11
Outcomes
MRSA infections (number, %)	1 (6)	3 (38)	0.09

n – number; IQR – interquartile range

Values are reported as number (%) unless otherwise specified